El Farargy O - Search Results

1

A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC).

Al-Saleh K, Abd El-Aziz N, Ali A, Abo Zeed W, Salah T, Elsamany S, Rasmy A, El Farargy O, Husain S, Al-Rikabi A, Alsaeed E, Aldiab A, Abd El-Warith A. Al-Saleh K, et al. Among authors: el farargy o. Gulf J Oncolog. 2019 May;1(30):33-42. Gulf J Oncolog. 2019. PMID: 31242980

2

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.

Elsayed DH, Elfarargy OM, Elderey MS, Mandour D, Atef N, Hemeda R, Kamel M, Azony A, Taha HF. Elsayed DH, et al. Contemp Oncol (Pozn). 2023;27(1):1-9. doi: 10.5114/wo.2023.126754. Epub 2023 Apr 27. Contemp Oncol (Pozn). 2023. PMID: 37266340 Free PMC article.

3

Prognostic Implications of CD24, SOX2, and Nanog Expression in Invasive Urothelial Carcinoma.

Abdelbary AM, Atwa HA, Elfarargy OM, Qasem ER, Elaidy NF. Abdelbary AM, et al. Appl Immunohistochem Mol Morphol. 2023 Jul 1;31(6):421-428. doi: 10.1097/PAI.0000000000001134. Epub 2023 Jun 7. Appl Immunohistochem Mol Morphol. 2023. PMID: 37278276

4

Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score.

Taha HF, Elsayed DH, Salem R, Mandour D, Bayomy M, Rashed H, Kamel M, Elderey M, Elfarargy OM. Taha HF, et al. Contemp Oncol (Pozn). 2022;26(3):196-203. doi: 10.5114/wo.2022.120592. Epub 2022 Oct 24. Contemp Oncol (Pozn). 2022. PMID: 36381673 Free PMC article.

5

The prognostic significance of p53, p63 and her2 expression in non-muscle-invasive bladder cancer in relation to treatment with bacille Calmette-Guerin.

Hegazy R, Kamel M, Salem EA, Salem NA, Fawzy A, Sakr A, El-Farargy O, Nawar N, El-Atar A, Shahin AM, Hegazy A. Hegazy R, et al. Among authors: el farargy o. Arab J Urol. 2015 Sep;13(3):225-30. doi: 10.1016/j.aju.2015.05.001. Epub 2015 Jul 17. Arab J Urol. 2015. PMID: 26413353 Free PMC article.

6

Association of CCND1 (c.723G > A, rs9344) variant with elevated risk of breast carcinoma: a retrospective case-control study.

El-Eshmawy MA, Shahin HE, El-Beltagy NS, Abdel Hamid D, Elfarargy OM, Elsayed DH, Elsaid AM, Elshazli RM, Mohamed NM. El-Eshmawy MA, et al. Mol Biol Rep. 2023 Mar;50(3):2015-2024. doi: 10.1007/s11033-022-08202-6. Epub 2022 Dec 19. Mol Biol Rep. 2023. PMID: 36534235

7

Down-regulated MiRNA 29-b as a diagnostic marker in colorectal cancer and its correlation with ETV4 and Cyclin D1 immunohistochemical expression.

Mosaad H, Ahmed MM, Elaidy MM, Elfarargy OM, Abdelwahab MM, Abdelnour HM. Mosaad H, et al. Cancer Biomark. 2023;37(3):179-189. doi: 10.3233/CBM-220349. Cancer Biomark. 2023. PMID: 37248886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters